If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDerwent London Regulatory News (DLN)

Share Price Information for Derwent London (DLN)

Share Price is delayed by 15 minutes
Get Live Data
1,971.00    -2.00 (-0.10%)
Bid:
1,969.00
Ask:
1,972.00
Spread: 3.00 (0.152%)
Market Cap: £2.19b
DLN Live PriceLast checked at - London Stock Exchange

Intraday Derwent London Share Chart

Network building fully pre-let

16 Mar 2026 07:00

RNS Number : 6416W
Derwent London PLC
16 March 2026
 

Derwent London plc ("Derwent London" / "the Group")

Network building fully pre-let

Derwent London is pleased to announce that it has pre-let the entire 136,300 sq ft of offices at Network W1 to Databricks, a data and AI company, on a 15-year lease with a break at year 10. The annual rent is £14.1m.

The London office market is entering a period of very low new supply while demand remains robust, sector diverse and focused on the right space in well-connected locations, supporting the strong rental growth outlook. Network provides amenity-rich, adaptable and sustainable space which meets the requirements of modern occupiers.

Paul Williams, Chief Executive of Derwent London, said:"We are delighted to have pre-let all of the offices at Network W1 to Databricks shortly before completion at a rent which reflects the quality of the space we are delivering. This maintains our long and successful pre-letting track record. Momentum is strong across the business and since the start of 2026, we have now agreed lettings totalling £15.7m of rent with lease renewals and regears adding a further £2.1m. In addition, we have £4.3m of transactions under offer."

For further information, please contact:

Derwent London

Tel: +44 (0)20 3478 4217 (Robert Duncan)

Paul Williams, Chief Executive

Emily Prideuax, Executive Director

Robert Duncan, Head of Investor Relations

Brunswick Group

Tel: +44 (0)20 7404 5959

Nina Coad

Peter Hesse

 

Notes to editors

Derwent London plc

Derwent London plc owns a commercial real estate portfolio predominantly in central London valued at £5.1 billion as at 31 December 2025, making it the largest London office-focused real estate investment trust (REIT).

Our experienced team has a long track record of creating value throughout the property cycle by regenerating our buildings via redevelopment or refurbishment, effective asset management and capital recycling. We typically acquire central London properties off-market with low capital values and modest rents in improving locations, most of which are either in the West End or City Borders. We capitalise on the unique qualities of each of our properties - taking a fresh approach to the regeneration of every building with a focus on anticipating tenant requirements and an emphasis on design. Reflecting and supporting our long-term success, the business has a strong balance sheet with modest leverage, a robust income stream and flexible financing.

We are frequently recognised in industry awards for the quality, design and innovation of our projects. Landmark buildings in our 5.3 million sq ft portfolio include 25 Baker Street W1, 1 Soho Place W1, 80 Charlotte Street W1, Brunel Building W2, White Collar Factory EC1, Angel Building EC1 and Tea Building E1.

As part of our commitment to lead the industry in mitigating climate change, Derwent London has committed to becoming a net zero carbon business by 2030, publishing its pathway to achieving this goal in 2020. Our science-based carbon targets have been validated by the Science Based Targets initiative (SBTi). In 2013, we launched a voluntary Community Fund which to date has supported 200 community projects in central London.

The Company is a public limited company, which is listed on the London Stock Exchange and incorporated and domiciled in the UK. The address of its registered office is 25 Savile Row, London, W1S 2ER.

For further information see www.derwentlondon.com or follow us on LinkedIn.

Forward-looking statements

This document contains certain forward-looking statements about the future outlook of Derwent London. By their nature, any forward-looking statements involve risk beyond the control of the management of Derwent London and may be subject to significant business, economic or competitive uncertainties, assumptions and contingencies or subjective judgments, including because they relate to events and depend on circumstances that may or may not occur in the future. These assumptions and judgments may or may not prove to be correct and actual results, performance or outcomes may differ materially from any results, performance or outcomes expressed or implied by such forward-looking statements. Any forward-looking statements have not been independently audited, examined or otherwise reviewed or verified.

No responsibility or liability is or will be accepted and no representation or warranty is or is authorised to be given in relation to any forward-looking statements made by Derwent London, including as to their completeness, reliability, reasonableness or accuracy, or of any assumption or estimate on the basis of which they have been given. This document speaks as of the date hereof. Derwent London does not undertake to provide access to any additional information or to update any forward-looking statements whether as a result of new information, to reflect future events or circumstances that arise after the date of this document, to correct any inaccuracies in this document which may become apparent or otherwise. Nothing in this announcement should be construed as a profit forecast.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCGPUQPWUPQGCW
Date   Source Headline
29th Apr 20224:45 pmRNSTotal Voting Rights
13th Apr 20222:00 pmRNSReport and Accounts 2021 and Notice of AGM
31st Mar 20224:45 pmRNSTotal Voting Rights
22nd Mar 20229:00 amRNSBlock listing Interim Review replacement
21st Mar 20226:10 pmRNSBlock listing Interim Review
15th Mar 202210:45 amRNSDirector/PDMR Shareholding
15th Mar 202210:45 amRNSDirector/PDMR Shareholding
10th Mar 20222:00 pmRNSDirector/PDMR Shareholding
10th Mar 202210:00 amRNSAdditional Listing
2nd Mar 20229:37 amRNSHolding(s) in Company
28th Feb 20224:45 pmRNSTotal Voting Rights
24th Feb 20227:00 amRNSResults for the Year Ended 31 December 2021
31st Jan 20224:45 pmRNSTotal Voting Rights
26th Jan 20227:00 amRNSSALE OF NEW RIVER YARD EC1
31st Dec 20211:30 pmRNSTotal Voting Rights
14th Dec 202111:16 amRNSTerms agreed to acquire City Road Island EC1
10th Dec 20219:23 amRNSHolding(s) in Company
6th Dec 20212:30 pmRNSHolding(s) in Company
1st Dec 20213:00 pmRNSHolding(s) in Company
1st Dec 20212:20 pmRNSHolding(s) in Company
30th Nov 20214:45 pmRNSTotal Voting Rights
10th Nov 20215:05 pmRNS£350M 10-YEAR 1.875% GREEN BOND
4th Nov 20217:01 amRNSAcquisition of 230 Blackfriars Road SE1
4th Nov 20217:00 amRNSThird Quarter Business Update
29th Oct 20214:45 pmRNSTotal Voting Rights
25th Oct 202111:30 amRNSHolding(s) in Company
14th Oct 20214:00 pmRNSHolding(s) in Company
14th Oct 20219:00 amRNSDirectorate Change
12th Oct 20217:00 amRNSDerwent London September 2021 Rent Collection
30th Sep 20214:45 pmRNSTotal Voting Rights
28th Sep 20218:00 amRNSInvestor and Analyst Presentation 2021
21st Sep 202110:00 amRNSAdditional Listing
20th Sep 20214:45 pmRNSBlock listing Interim Review
31st Aug 20214:45 pmRNSTotal Voting Rights
10th Aug 20217:01 amRNSACQUISITION OF TWO PROPERTIES & NEW JV
10th Aug 20217:00 amRNSINTERIM RESULTS
6th Aug 20212:45 pmRNSDirectorate Change
2nd Aug 20217:00 amRNSAcquisition of Bush House, SW Wing, WC2, Headlease
30th Jul 20214:45 pmRNSTotal Voting Rights
29th Jul 20217:00 amRNSFORA LETS 6-8 GREENCOAT PLACE
19th Jul 20217:00 amRNSDisposal of Angel Square EC1 to Tishman Speyer
9th Jul 20217:00 amRNSJune 2021 Rent Collection
30th Jun 20214:45 pmRNSTotal Voting Rights
22nd Jun 20213:30 pmRNSHolding(s) in Company
1st Jun 202110:00 amRNSTotal Voting Rights
18th May 20211:00 pmRNSDirector/PDMR Shareholding
14th May 202112:10 pmRNSResults of 2021 Annual General Meeting
10th May 202110:30 amRNSBondholders Meetings
6th May 20217:00 amRNSQ1 2021 Business Update
30th Apr 20214:45 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.